Market Cap | ₹31,955Cr |
ROE | 7.63% |
P/E Ratio(TTM) | 41.49 |
EPS(TTM) | 46.75 |
P/B Ratio | 3.49 |
Dividend Yield | 0.93% |
Industry P/E | 34.33 |
Book Value | 555.41 |
Debt to Equity | 0.03 |
Face Value | 1 |
Parent Organisation | Gland Pharma Limited |
Managing Director | Mr. Srinivasa Sadu |
NSE Symbol | GLAND |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 59.59 | ||
Ajanta Pharma | NA (0.00%) | 32.66 | ||
Eris Lifesciences | NA (0.00%) | 56.56 | ||
Sai Life Sciences | NA (0.00%) | 74.27 |